​

Funding Round

Series C - Thyme Care

Series C - Thyme Care

Investment Firm

Overview

Thyme Care is a healthcare company that provides oncology care management services.

Announced Date

Jul 16, 2024

Closed on Date

Jul 16, 2024

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Concord Health Partners

Concord Health Partners

Concord Health Partners is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

7

Investor Name
Participant InvestorFrist Cressey Ventures
Participant InvestorEcho Health Ventures
Participant InvestorForesite Capital
Participant InvestorAlleyCorp
Participant InvestorAndreessen Horowitz

Round Details and Background

Thyme Care raised $55000000 on 2024-07-16 in Series C

Thyme Care is a healthcare company that provides oncology care management services.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 21, 2023
Series B - Thyme Care
6-60.0M
May 28, 2024
Venture Round - Thyme Care
2-undefined
Jul 16, 2024
Series C - Thyme Care
8-55.0M
Jul 16, 2024
Debt Financing - Thyme Care
1-40.0M

Recent Activity

There is no recent news or activity for this profile.